Supreme Court urged to maintain restrictions on mifepristone by anti-abortion groups and drug companies.

Anti-abortion doctors have urged the US Supreme Court to reinstate a lower court decision that suspended government approval of a medication used in more than half of pregnancy terminations in the United States, saying the Food and Drug Administration has “stripped away every meaningful and necessary safeguard on chemical abortion.” The Supreme Court put the 5th Circuit opinion on hold temporarily last week and will decide by midnight Wednesday whether to maintain full access to mifepristone while the case is appealed. The case is the court’s most notable consideration of abortion rights since its landmark decision last June to overturn the guarantee of abortion rights provided in Roe v. Wade.